ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Critical Care Medicine

Top Critical Care Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GERALD HARRINGTON M.D.

Critical Care Medicine

30,650

$1.88M

691
561 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

28%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 53%

$61
Average prescription price

Avg: $134

LORENZO PELLY M.D.

Critical Care Medicine

19,766

$1.75M

912
715 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 53%

$89
Average prescription price

Avg: $134

CRISTINA ASERON MD

Critical Care Medicine

16,185

$1.09M

691
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 53%

$68
Average prescription price

Avg: $134

IFTIKHAR ALI M.D.

Critical Care Medicine

6,111

$275K

270
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 53%

$45
Average prescription price

Avg: $134

DAUD ASHAI M.D

Critical Care Medicine

3,757

$229K

245
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

24%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 53%

$61
Average prescription price

Avg: $134

THEODORE MCLEMORE M.D. PH.D

Critical Care Medicine

3,570

$748K

485
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

81%
prescriptions for brand name drugs

Avg: 53%

$210
Average prescription price

Avg: $134

HISHAM BISMAR M.D.

Critical Care Medicine

3,215

$634K

358
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 53%

$197
Average prescription price

Avg: $134

LISA ROY M.D.

Critical Care Medicine

2,769

$166K

150
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

28%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 53%

$60
Average prescription price

Avg: $134

ADOLFO KAPLAN M.D.

Critical Care Medicine

2,565

$804K

485
390 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 53%

$313
Average prescription price

Avg: $134

JUAN ORTIZ M.D.

Critical Care Medicine

2,474

$459K

555
450 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 53%

$186
Average prescription price

Avg: $134

HAROLD CAIN M.D.

Critical Care Medicine

2,226

$413K

181
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 53%

$186
Average prescription price

Avg: $134

STEPHEN MUELLER M.D.

Critical Care Medicine

2,203

$319K

349
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 53%

$145
Average prescription price

Avg: $134

MOHAN PHILIP M.D

Critical Care Medicine

2,105

$292K

283
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

66%
prescriptions for brand name drugs

Avg: 53%

$139
Average prescription price

Avg: $134

RICARDO ABREU M.D.

Critical Care Medicine

1,439

$306K

379
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 53%

$212
Average prescription price

Avg: $134

DEBORAH LEVINE MD

Critical Care Medicine

1,437

$2.55M

94
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 53%

$1777
Average prescription price

Avg: $134

FRANCIS AMEDE MD

Critical Care Medicine

1,317

$66.4K

118
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 53%

$50
Average prescription price

Avg: $134

AHMAD HAJJ M.D., F.C.C.P.

Critical Care Medicine

1,298

$192K

196
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 53%

$148
Average prescription price

Avg: $134

JOEL JOHNSON M.D.

Critical Care Medicine

1,134

$177K

223
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 53%

$156
Average prescription price

Avg: $134

GHASSAN NOUREDDINE M.D.

Critical Care Medicine

1,088

$156K

167
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 53%

$143
Average prescription price

Avg: $134

ROBERT MORRISON M.D.

Critical Care Medicine

1,084

$355K

101
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 53%

$328
Average prescription price

Avg: $134

MALLADI SASTRY MD

Critical Care Medicine

1,015

$118K

161
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 53%

$116
Average prescription price

Avg: $134

DAN SCHULLER M.D.

Critical Care Medicine

1,004

$1.12M

81
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 53%

$1115
Average prescription price

Avg: $134

DAVID BERZON M.D.

Critical Care Medicine

926

$172K

209
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 53%

$186
Average prescription price

Avg: $134

DIVINA TUAZON M.D.

Critical Care Medicine

777

$115K

121
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 53%

$148
Average prescription price

Avg: $134

JEFF TAYLOR M.D.

Critical Care Medicine

723

$49.8K

129
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 53%

$69
Average prescription price

Avg: $134

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank